Coronary Artery Disease (CAD)

Beta-Blockers in Patients with Hypertension and Cardiovascular Disease: When to Start and When to Continue

by Prateek Chopra | June 13, 2026 | Cardiology Conferences | ESH 2026 Personalized Obesity Care: Obesity is a chronic, relapsing adiposity-based disease leading to mechanical and metabolic complications via complex genetic, biological, and environmental interactions. Effective management requires a patient-centered approach combining lifestyle interventions, nutrition, physical activity, pharmacotherapy, and bariatric surgery when appropriate. Evidence-Based Framework: Treatment Principles: Key Insights & […]

Beta-Blockers in Patients with Hypertension and Cardiovascular Disease: When to Start and When to Continue Read Post »

Leave a Comment / ESH Day 3 / / / , , , ,

Integrated Polygenic Scores: Are They Ready for Clinical Practice?

by Prateek Chopra | June 7, 2026 | Cardiology Conferences | ESH 2026 Precision Cardiovascular Prevention: Integrated polygenic risk scores (PRS) enhance risk stratification beyond traditional risk factors. PRS predicts coronary artery disease (CAD) 2–4 times more strongly than conventional risk factors and identifies high-risk individuals not captured by family history or standard clinical assessments. High-Risk Populations: Evidence from Clinical Trials:

Integrated Polygenic Scores: Are They Ready for Clinical Practice? Read Post »

Leave a Comment / ESH Day 2 / / / , , , ,
Scroll to Top